Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial

Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    1%
    Check dated 2025-05-08T04:54:27.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    1%
    Check dated 2025-05-01T00:51:18.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-04-23T18:07:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study on acute myeloid leukemia and myelodysplastic syndromes, while adding new terminology related to leukemia and a new revision number.
    Difference
    35%
    Check dated 2025-04-16T14:06:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T08:41:48.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.6%
    Check dated 2025-04-01T23:04:54.000Z thumbnail image

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.